16 results match your criteria: "University Hospital Marburg and Philipps University[Affiliation]"

European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours.

J Neuroendocrinol

September 2024

Department of Medicine 1, Friedrich-Alexander University Erlangen-Nürnberg, ENETS Center of Excellence Erlangen, CCC Erlangen- EMN, and Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.

Article Synopsis
  • The incidence and prevalence of well-differentiated small intestine neuroendocrine tumors (Si-NET) are rising, with most cases being non-functioning and often discovered incidentally during routine procedures or late-stage imaging.
  • About 30% of patients experience symptoms related to the carcinoid syndrome, highlighting the disease's subtle presentation.
  • Effective treatment planning requires thorough biochemical assessment and staging, ideally conducted in specialized ENETS Centres of Excellence or expert centers, as outlined in guidance focusing on management strategies for Si-NET grades 1-3.
View Article and Find Full Text PDF

Lung carcinoid tumours are neuroendocrine neoplasms originating from the bronchopulmonary tract's neuroendocrine cells, accounting for only 1%-3% of all lung cancers but 30% of all neuroendocrine tumours. The incidence of lung carcinoids, both typical and atypical, has been increasing over the years due to improved diagnostic methods and increased awareness among clinicians and pathologists. The most recent WHO classification includes a subgroup of lung carcinoids with atypical morphology and higher mitotic count and/or Ki67 labelling index.

View Article and Find Full Text PDF

This ENETS guidance paper, developed by a multidisciplinary working group, provides an update on the previous colorectal guidance paper in a different format. Guided by key clinical questions practical advice on the diagnosis and management of neuroendocrine tumours (NET) of the caecum, colon, and rectum is provided. Although covered in one guidance paper colorectal NET comprises a heterogeneous group of neoplasms.

View Article and Find Full Text PDF

Portal venous gas detection in different clinical situations.

Med Ultrason

September 2023

Hirslanden Kliniken Bern, Department of Internal Medicine (DAIM), Bern, Switzerland.

Portal Venous Gas (PVG) provides an important differential diagnosis in the diagnose of intrahepatic reflexogenic structures. This review article is intended to provide an overview of the current literature on the detection of PVG, its special forms and important differential diagnoses, it also shows possibilities for the diagnostic procedure in the case of sonographic detection of PVG.

View Article and Find Full Text PDF

Objective: Oesophageal cancer (EC) is the sixth leading cause of cancer-related deaths. Oesophageal adenocarcinoma (EA), with Barrett's oesophagus (BE) as a precursor lesion, is the most prevalent EC subtype in the Western world. This study aims to contribute to better understand the genetic causes of BE/EA by leveraging genome wide association studies (GWAS), genetic correlation analyses and polygenic risk modelling.

View Article and Find Full Text PDF

Background: Notch signaling controls cell fate decisions in many contexts during development and adult stem cell homeostasis and, when dysregulated, leads to carcinogenesis. The central transcription factor RBPJ assembles the Notch coactivator complex in the presence of Notch signaling, and represses Notch target gene expression in its absence.

Results: We identified L3MBTL2 and additional members of the non-canonical polycomb repressive PRC1.

View Article and Find Full Text PDF

Reply to Y. Kawamura et al.

J Clin Oncol

September 2021

Sibylle Loibl, MD, PhD, German Breast Group c/o GBG Forschungs GmbH, Neu-Isenburg, Germany, Center for Hematology and Oncology Bethanien, Frankfurt, Germany; Valentina Nekljudova, PhD, German Breast Group c/o GBG Forschungs GmbH, Neu-Isenburg, Germany; and Carsten Denkert, MD, PhD, Institute of Pathology, University Hospital Marburg and Philipps-University Marburg, Marburg, Germany.

View Article and Find Full Text PDF

Gastroenteropancreatic neuroendocrine neoplasia (GEPNEN) comprises clinically as well as prognostically diverse tumour entities often diagnosed at late stage. Current classification provides a uniform terminology and a Ki67-based grading system, thereby facilitating management. Advances in the study of genomic and epigenetic landscapes have amplified knowledge of tumour biology and enhanced identification of prognostic and potentially predictive treatment subgroups.

View Article and Find Full Text PDF

Background: The aim of this study was to evaluate via finite element analysis (FEA) the biomechanical behavior of conventional small-fragment screws reinforced by a patient-specific plate in type p condylar head.

Methods: A finite element model of the mandible was created using Mimics 12.1 software.

View Article and Find Full Text PDF

Objectives: The aim of the present study was to improve the accuracy and reliability of ORIF in patients with condylar head fractures (CHFs) by developing a design for patient specific fixators, navigation and repositioning guides, as well as the algorithms of their clinical application.

Materials And Methods: 14 patients with 16 CHFs were treated by ORIF with the use of CAD/CAM technology. After virtual reduction of the bony fragments, the appropriate length and diameter of the screws was chosen.

View Article and Find Full Text PDF

Veno-occlusive disease (VOD) is a severe complication of allogeneic stem cell transplantation (allo-SCT). Its diagnosis is difficult, and ultrasound (US) has not been proven to be of additional diagnostic value. In the work described here, we prospectively analyzed the hepatic contrast-enhanced ultrasound (CEUS) pattern before and after allo-SCT and correlated these results with the pre-allo-SCT VOD risk factors, clinical VOD findings and conventional US findings.

View Article and Find Full Text PDF

Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3.

Am J Surg

August 2020

Department of Medicine 1, Division of Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany; Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Mitte, Charité Universitätsmedizin, Berlin, Germany.

Background: Stage IV gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) G3 are the NENs with the worst prognosis. According to ENETS guidelines, platinum-based chemotherapy is the standard treatment for this population. Surgery is only considered in highly selected "resectable" NENs with usually lower Ki67.

View Article and Find Full Text PDF

Background: While platinum-based chemotherapy represents the standard treatment for advanced grade 3 (G3) neuroendocrine neoplasms (NENs) according to the European Neuroendocrine Tumor Society guidelines, the role of radical-intended surgery in these patients, as well as the use of adjuvant chemotherapy, are still controversial. The aim of the present work is to describe, in a retrospective series of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) G3, the overall survival (OS) rate and risk factors for death after radical surgery. Secondary aims are the description of median recurrence-free survival (RFS) and of the role of adjuvant chemotherapy.

View Article and Find Full Text PDF

Patients with tumor-related epilepsy (TRE) represent an important proportion of epilepsy surgery cases. Recently established independent negative predictors of postoperative seizure outcome are long duration of epilepsy, presence of generalized tonic-clonic seizures, and incomplete tumor resection. In temporal lobe cases, additional hippocampectomy or corticectomy may further improve outcome.

View Article and Find Full Text PDF